Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria

Details

• Alternative Title:
  Clin Infect Dis
• Personal Author:
  Schultz, Jonathan S. ; Mace, Kimberly E. ; Tan, Kathrine R.
• Description:
  Return to international travel in the COVID-19 pandemic recovery period is expected to increase the number of patients with imported malaria in the United States (US). Malaria prevention in travelers and preparedness for timely diagnosis and appropriate treatment are key to minimize imported malaria morbidity and mortality. Intravenous artesunate (IVAS) is now available from commercial distributors in the US for the treatment of severe malaria. Hospitals and pharmacists should have a plan for malaria treatment, including stocking artemether-lumefantrine for uncomplicated malaria, and stocking or planning for rapid procurement of IVAS for the treatment of severe malaria.
• Subjects:
  Antimalarials Artemether Artemether, Lumefantrine Drug Combination Artesunate COVID-19 COVID-19 Testing Early Diagnosis Humans Malaria Malaria, Falciparum Pandemics Travel United States

  More +
• Keywords:
  Artesunate Chemoprophylaxis Malaria Plasmodium Falciparum Travel
• Source:
  Clin Infect Dis. 76(7):1161-1163
• Pubmed ID:
  36723870
• Pubmed Central ID:
  PMC10450225
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  76
• Issue:
  7
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:6a5716e8f8b2da00e128c8a523ea151b9022d82790736fd2c8d795ce66356913
• Download URL:
  https://stacks.cdc.gov/view/cdc/132372/cdc_132372_DS1.pdf
• File Type:
  [PDF - 494.61 KB ]